AZN insider buying and SEC filings, explained
Astrazeneca plc · CIK 901832
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$2.2M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 8, 2026 | Purchase (code P) | Mani Sharma (Officer) bought 20 shares at $160.57 ($3K), reported as a purchase (code P). Holdings up <1% to 19,288 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 11, 2026 |
| May 20, 2026 | Sale | Mani Sharma (Officer) sold 11,893 shares at $185.78 ($2.2M). Holdings down 38% to 19,262 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
6 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AZN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.